← Evidence map

ReviewCancer biology & therapy2020

Third-line sunitinib treatment in a

Xiaofen Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 32552305